Hope for Immuron anti-diarrhoea vaccine
Biotechnology company Immuron has announced positive results for its anti-diarrhoea vaccine in targeting the main bacteria responsible for sickness that besets international travellers and personnel stationed overseas such as the military. The United States Naval Research Centre (NMRC) has completed analysis of cows vaccinated against Campylobacter and Entereotoxigenic Escherichia coli, noting a ‘robust immune response’.…